JYB1904

DRUG6 trials

Sponsors

Jemincare

Conditions

Allergic AsthmaAllergic DiseasesChronic Spontaneous UrticariaHealthyPerennial Allergic Rhinitis

Phase 1

Study of JYB1904 (an Anti-immunoglobulin E Antibody) in Healthy Chinese Subjects

CompletedNCT05449535

JemincareHealthy

Start: 2022-05-07End: 2023-01-10Updated: 2023-06-27

Trial of JYB1904 Injection in Adolescent Participants

Not yet recruitingNCT07513857

JemincareAllergic Diseases

Start: 2026-05-17End: 2027-07-30Target: 12Updated: 2026-04-07

Phase 2

Trial of JYB1904 in Patients With Allergic Asthma

CompletedNCT06438757

JemincareAllergic Asthma

Start: 2024-06-19End: 2025-12-20Updated: 2026-06-15

Trial of JYB1904 in Chronic Spontaneous Urticaria.

RecruitingNCT06509334

JemincareChronic Spontaneous Urticaria

Start: 2024-08-04End: 2026-07-15Target: 135Updated: 2024-11-29

Trial of JYB1904 Injection in Patients With Perennial Allergic Rhinitis

Not yet recruitingNCT07459452

JemincarePerennial Allergic Rhinitis

Start: 2026-04-01End: 2028-10-01Target: 135Updated: 2026-03-09

Phase 3

Trial of JYB1904 Injection in Adult Patients With Chronic Spontaneous Urticaria.

RecruitingNCT07402213

JemincareChronic Spontaneous Urticaria

Start: 2026-03-09End: 2028-06-09Target: 240Updated: 2026-08-03